Large artery stiffness assessment has been an integral part of the SphygmoCor technology since 1998. Aortic stiffness is approximated with non-invasive measurement of carotid-femoral pulse wave velocity, with improvements made with time to make the assessment procedure quicker and more user independent. Also standard in the devices is the ability to reliably calculate the central aortic waveform shape from a peripheral pressure waveform from either the brachial or radial artery. This waveform contains much information beyond peak and trough (systolic and diastolic pressure). Relative waveform features such as the augmentation index, wave reflection magnitude, reflection time index, and subendocardial viability ratio are parameters that are influenced by the stiffness of systemic arteries. This article briefly describes these parameters related to large artery stiffness and provides reference to validation and repeatability studies relative to the clinical use of the SphygmoCor devices. It is beyond the scope to review here the 424 original research articles that have employed SphygmoCor devices in measuring arterial stiffness. Instead, the method of measurement across the devices is described, including tonometry, volumetric displacement through cuff placement around limbs, and ambulatory monitoring. Key population and subpopulation studies are cited where the average stiffness parameter progression with age and gender, as measured by SphygmoCor devices, is quantified in the healthy and general population. Finally, with reference to guidelines from working groups on arterial stiffness and hypertension, the clinical utility of large artery stiffness measurement is discussed in the context of the arterial stiffness parameters provided by the SphygmoCor systems.

Keywords:
Large artery stiffness, SphygmoCor technology
1.
Butlin M, Avolio AP: Age-related changes in the mechanical properties of arteries; in Derby B, Akhtar R (eds): Mechanical Properties of Aging Soft Tissue. New York, Springer, 2014, pp 37-74.
2.
Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31:1865-1871.
3.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al: 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187.
4.
Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al: Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014;63:636-646.
5.
Hickson SS, Butlin M, Graves M, Taviani V, Avolio AP, McEniery CM, et al: The relationship of age with regional aortic stiffness and diameter. JACC Cardiovasc Imaging 2010;3:1247-1255.
6.
McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR: Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760.
7.
Wilkinson IB, McEniery CM, Schillaci G, Boutouyrie P, Segers P, Donald A, et al: ARTERY Society guidelines for validation of non-invasive haemodynamic measurement devices: part 1, arterial pulse wave velocity. Artery Res 2010;4:34-40.
8.
Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, et al: Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998;16(pt 2):2079-2084.
9.
Frimodt-Møller M, Nielsen AH, Kamper A-L, Strandgaard S: Reproducibility of pulse-wave analysis and pulse-wave velocity determination in chronic kidney disease. Nephrol Dial Transplant 2008;23:594-600.
10.
Weber T, Ammer M, Rammer M, Adji A, O'Rourke MF, Wassertheurer S, et al: Noninvasive determination of carotid-femoral pulse wave velocity depends critically on assessment of travel distance: a comparison with invasive measurement. J Hypertens 2009;27:1624-1630.
11.
Huybrechts SAM, Devos DG, Vermeersch SJ, Mahieu D, Achten E, de Backer TLM, et al: Carotid to femoral pulse wave velocity: a comparison of real travelled aortic path lengths determined by MRI and superficial measurements. J Hypertens 2011;29:1577-1582.
12.
Shiburi CP, Staessen JA, Maseko M, Wojciechowska W, Thijs L, Van Bortel LM, et al: Reference values for SphygmoCor measurements in South Africans of African ancestry. Am J Hypertens 2006;19:40-46.
13.
Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, et al: Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985;71:202-210.
14.
Butlin M, Qasem A, Battista F, Bozec E, McEniery CM, Millet-Amaury E, et al: Carotid-femoral pulse wave velocity assessment using novel cuff-based techniques: comparison with tonometric measurement. J Hypertens 2013;31:2237-2243.
15.
Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP: An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993;14:160-167.
16.
Wilkinson IB, Mohammad NH, Tyrrell S, Hall IR, Webb DJ, Paul VE, et al: Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002;15(pt 1):24-30.
17.
Takazawa K, O'Rourke MF, Fujita M, Tanaka N, Takeda K, Kurosu F, et al: Estimation of ascending aortic pressure from radial arterial pressure using a generalised transfer function. Z Kardiol 1996;85(suppl 3):137-139.
18.
Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, et al: Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997;95:1827-1836.
19.
Söderström S, Nyberg G, O'Rourke MF, Sellgren J, Pontén J: Can a clinically useful aortic pressure wave be derived from a radial pressure wave? Br J Anaesth 2002;88:481-488.
20.
O'Rourke MF, Pauca AL: Augmentation of the aortic and central arterial pressure waveform. Blood Press Monit 2004;9:179-185.
21.
Hwang MH, Yoo JK, Kim HK, Hwang CL, Mackay K, Hemstreet O, et al: Validity and reliability of aortic pulse wave velocity and augmentation index determined by the new cuff-based SphygmoCor Xcel. J Hum Hypertens 2014;28:475-481.
22.
Filipovský J, Svobodová V, Pecen L: Reproducibility of radial pulse wave analysis in healthy subjects. J Hypertens 2000;18:1033-1040.
23.
Siebenhofer A, Kemp C, Sutton A, Williams B: The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens 1999;13:625-629.
24.
Papaioannou TG, Stamatelopoulos KS, Gialafos E, Vlachopoulos C, Karatzis E, Nanas J, et al: Monitoring of arterial stiffness indices by applanation tonometry and pulse wave analysis: reproducibility at low blood pressures. J Clin Monit Comput 2004;18:137-144.
25.
Savage MT, Ferro CJ, Pinder SJ, Tomson CRV: Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond) 2002;103:59-65.
26.
Westerhof N, Sipkema P, van den Bos GC, Elzinga G: Forward and backward waves in the arterial system. Cardiovasc Res 1972;6:648-656.
27.
Westerhof BE, Guelen I, Westerhof N, Karemaker JM, Avolio A: Quantification of wave reflection in the human aorta from pressure alone: a proof of principle. Hypertension 2006;48:595-601.
28.
Qasem A, Avolio AP: Determination of aortic pulse wave velocity from waveform decomposition of the central aortic pressure pulse. Hypertension 2008;51:188-195.
29.
Crilly M, Coch C, Bruce M, Clark H, Williams D: Indices of cardiovascular function derived from peripheral pulse wave analysis using radial applanation tonometry: a measurement repeatability study. Vasc Med 2007;12:189-197.
30.
Goodwin J, Bilous M, Winship S, Finn P, Jones SC: Validation of the Oscar 2 oscillometric 24-h ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood Press Monit 2007;12:113-117.
31.
Jones SC, Bilous M, Winship S, Finn P, Goodwin J: Validation of the OSCAR 2 oscillometric 24-hour ambulatory blood pressure monitor according to the International Protocol for the validation of blood pressure measuring devices. Blood Press Monit 2004;9:219-223.
32.
Gedikli O, Ozturk S, Yilmaz H, Baykan M, Kiris A, Durmus I, et al: Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension. Am J Hypertens 2008;21:989-993.
33.
Rossi SH, McQuarrie EP, Miller WH, Mackenzie RM, Dymott JA, Moreno MU, et al: Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease. BMC Nephrol 2013;14:173.
34.
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085-2090.
35.
Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, et al: Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005;45:980-985.
36.
Nichols WW, Denardo SJ, Davidson JB, Huo T, Bairey Merz CN, Pepine CJ: Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: an ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Am J Heart;170:1243-1254.
37.
Weber T, Auer J, Lamm G, O'Rourke MF, Eber B: Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy - implications for risk stratification. J Card Fail 2007;13:353-359.
38.
Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Lamm G, et al: Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 2005;26:2657-2663.
39.
Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF: Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983;68:50-58.
40.
Filipovský J, Tichá M, Cífková R, Lánská V, Stastná V, Roucka P: Large artery stiffness and pulse wave reflection: results of a population-based study. Blood Press 2005;14:45-52.
41.
Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E: Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device. Am J Hypertens 2010;23:180-185.
42.
Li Y, Staessen JA, Li LH, Huang QF, Lu L, Wang JG: Reference values for the arterial pulse wave in Chinese. Am J Hypertens 2008;21:668-673.
43.
Al-Hashmi KM, Al-Abri MA, Al-Zakwani IS, Al-Waili KA, Al-Rasadi KH, Al-Sabti HA, et al: Reference values for arterial stiffness indices in an Omani Arab population. Saudi Med J 2014;35:1367-1372.
44.
Wojciechowska W, Staessen JA, Nawrot T, Cwynar M, Seidlerová J, Stolarz K, et al: Reference values in white Europeans for the arterial pulse wave recorded by means of the SphygmoCor device. Hypertens Res 2006;29:475-483.
45.
Townsend RR, Black HR, Chirinos JA, Feig PU, Ferdinand KC, Germain M, et al: Clinical use of pulse wave analysis: proceedings from a symposium sponsored by North American Artery. J Clin Hypertens (Greenwich) 2015;17:503-513.
46.
Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, et al: Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012;30:445-448.
47.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al: 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-2219.
48.
Hallock P: Arterial elasticity in man in relation to age as evaluated by the pulse wave velocity method. Arch Intern Med 1934;54:770-798.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.